ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

February 27, 2009

American Cancer Society Awards its Medal of Honor

May 24, 2013

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998

Minority Professional Training Concept Gets Approval Of NCAB

March 1, 1991

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975